中性粒細胞減少症和感染 – 安健腫瘤治療中心中性粒細胞減少症和感染
Neutropenia and Infection
Many chemotherapy drugs cause a lowering of infection-fighting white blood cells in your body—a condition known as neutropenia. This serious condition can increase your risk of developing an infection and affect your chemotherapy schedule. A simple blood test, called a complete blood count (CBC), detects neutropenia. Fortunately, neutropenia is easily prevented or reduced. If needed, your doctor will prescribe Neulasta® (pegfilgrastim) or Neupogen® (filgrastim), the short-acting form of Neulasta. These medications help your body produce more white blood cells and prevent the complications of neutropenia. You may be at greater risk of developing an infection if you have previously received chemotherapy or radiation treatment, you’re receiving intensive chemotherapy, you’re 62 or older, or you have open wounds or other conditions that affect your immune system. In those cases, Neulasta is given with the first cycle of chemotherapy and then with each remaining chemotherapy dose. This can reduce the risk of infection (neutropenia with fever) by more than 90 percent. Contact your doctor or nurse immediately if you have any sign of fever or infection while on chemotherapy.
Tips for Managing Neutropenia and Infection
|